Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich coiled-coil 2C pseudogene 1 (PRRC2CP1) is classified as a pseudogene, meaning it is a non-functional segment of DNA resembling a protein-coding gene but contains mutations or alterations that prevent transcription into a functional protein. While pseudogenes can participate in regulatory mechanisms within the cell, such as modulating gene expression, acting as microRNA decoys, or generating small interfering RNAs, PRRC2CP1 itself does not function as a therapeutic target, receptor, or enzyme. Its presence in genomic databases primarily aids in annotation and understanding of genomic evolution and gene regulation, but there is no evidence it encodes a functional protein or is directly relevant in clinical therapeutic contexts[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich coiled-coil 2C pseudogene 1 (PRRC2CP1).